FY2025 EPS Estimates for RNA Decreased by Cantor Fitzgerald
Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) – Stock analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for shares of Avidity Biosciences in a research report issued to clients and investors on Monday, May 12th. Cantor Fitzgerald analyst E. Schmidt now anticipates that the biotechnology company will earn ($4.46) per share for the year, […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) – Stock analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for shares of Avidity Biosciences in a research report issued to clients and investors on Monday, May 12th. Cantor Fitzgerald analyst E. Schmidt now anticipates that the biotechnology company will earn ($4.46) per share for the year, […]
